Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @SleekMoneycom | 10 |
| @biotech_sector | 8 |
| @dakotafinancial | 8 |
| @ChartMill | 7 |
| @IRAMarketReport | 6 |
Recent Tweets for MYGN
 |
@midetimes Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/FgcayWJqCA September 25th 2017, 3:09am |
 |
@dailypoliticaln Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/IMSLt8YQSd September 25th 2017, 3:09am |
 |
@WKRBNews Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/Q1lGa9lLqh September 25th 2017, 3:09am |
 |
@dailymailtimes Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/d24shb1bqq September 25th 2017, 3:09am |
 |
@SleekMoneycom Baillie Gifford & Co. Has $249.75 Million Stake in Myriad Genetics, Inc. $MYGN https://t.co/LVCYMjf8m1 September 25th 2017, 2:09am |
 |
@BigWaveTrading Top Current Holding Update: $MYGN +98% in 7 1/4 months. Signal: 2/14. Entry: 2/15 @ 16.96. #trading #investing… https://t.co/1Y01XbCMDE September 24th 2017, 3:09pm |
 |
@chaffeybreeze Myriad Genetics, Inc. $MYGN Holdings Decreased by Prudential Financial Inc. https://t.co/joW5qPsmeX September 24th 2017, 5:09am |
 |
@IRAMarketReport Myriad Genetics, Inc. $MYGN Holdings Decreased by Prudential Financial Inc. https://t.co/Ivr5znRJAO September 24th 2017, 5:09am |
 |
@PolgarStocks stockcharts: MYGN 33.79 Updated: 09-24-2017 $MYGN Last Trade: 9/22/2017 Last 33.79 - Open 33.88 Previo https://t.co/TTYHMHGlzq September 24th 2017, 5:09am |
 |
@storminvestor Myriad Genetics, Inc. $MYGN Given “Overweight” Rating at Stephens https://t.co/kN6jQFtHfC September 23rd 2017, 12:09pm |
 |
@SPNewsAnalysis Myriad Genetics, Inc. $MYGN Given “Overweight” Rating at Stephens https://t.co/mSBpxwLcRE September 23rd 2017, 12:09pm |
 |
@dakotafinancial Myriad Genetics $MYGN Earning Somewhat Positive Press Coverage, Analysis Finds https://t.co/bsvKOIpmOU September 23rd 2017, 9:09am |
 |
@WatchlistN Schwab Charles Investment Management Inc. Trims Position in Myriad Genetics, Inc. $MYGN https://t.co/HdveuBNlrV September 23rd 2017, 4:09am |
|
@dakotafinancial Myriad Genetics, Inc. $MYGN Reaches New 52-Week High at $33.73 https://t.co/3OnZbCcDNh September 23rd 2017, 3:09am |
 |
@bankerstribune Stephens reiterated Myriad Genetics $MYGN at Overweight. This 10yr DCF shows nice Upside https://t.co/kfPllNEo5F September 22nd 2017, 5:09pm |
|
@SPNewsAnalysis Myriad Genetics, Inc. $MYGN Expected to Post Quarterly Sales of $182.22 Million https://t.co/Y51coFhGpP September 22nd 2017, 3:09pm |
|
@storminvestor Myriad Genetics, Inc. $MYGN Expected to Post Quarterly Sales of $182.22 Million https://t.co/zuJEFmgmqJ September 22nd 2017, 3:09pm |
 |
@TheMarketsDaily Myriad Genetics, Inc. $MYGN Position Boosted by Pinebridge Investments L.P. https://t.co/ij5GfmbCX3 September 22nd 2017, 10:09am |
 |
@ZolmaxNews Myriad Genetics, Inc. $MYGN Shares Sold by GSA Capital Partners LLP https://t.co/cOQzD09lqq September 22nd 2017, 10:09am |
 |
@CFinancialNews Myriad Genetics’ $MYGN “Overweight” Rating Reiterated at Stephens https://t.co/QkJ44WACtd September 22nd 2017, 9:09am |
 |
@intercooleronli Myriad Genetics’ $MYGN “Overweight” Rating Reiterated at Stephens https://t.co/UOFVHSEWcy September 22nd 2017, 9:09am |
 |
@RatingsNetwork Myriad Genetics's overweight rating reiterated at Stephens. $40.00 PT. https://t.co/gBb8l4Tzo0 $MYGN #MYGN September 22nd 2017, 8:09am |
 |
@ProVesting $MYGN: Myriad Genetics (MYGN) PT Raised to $40 at Stephens: https://t.co/xjUeJQipaI September 22nd 2017, 8:09am |
 |
@pnani456 RT @AnalystWire: Myriad Genetics $MYGN PT Raised to $40 at Stephens https://t.co/MlYjpEIEb0 September 22nd 2017, 8:09am |
 |
@AnalystWire Myriad Genetics $MYGN PT Raised to $40 at Stephens https://t.co/MlYjpEIEb0 September 22nd 2017, 8:09am |
 |
@DavidTraderX $mygn still showing strength even with market slowing September 22nd 2017, 7:09am |
|
@SleekMoneycom Financial Survey: Myriad Genetics $MYGN versus Sequenom $SQNM https://t.co/qBJM3n8Lwk September 21st 2017, 5:09pm |
|
@chaffeybreeze Myriad Genetics, Inc. $MYGN Reaches New 52-Week High at $33.73 https://t.co/YITsqL9MSu September 21st 2017, 2:09pm |
|
@IRAMarketReport Myriad Genetics, Inc. $MYGN Reaches New 52-Week High at $33.73 https://t.co/BNthylDQet September 21st 2017, 2:09pm |
|
@SPNewsAnalysis Head-To-Head Analysis: VAREX IMAGING $VREX versus Myriad Genetics $MYGN https://t.co/kUA67v9PIp September 21st 2017, 9:09am |
|
@storminvestor Head-To-Head Analysis: VAREX IMAGING $VREX versus Myriad Genetics $MYGN https://t.co/q7tMlqZGX0 September 21st 2017, 9:09am |
|
@DavidTraderX $MYGN one of best performing biotechs of year #biotech #stockoftheday September 21st 2017, 8:09am |
|
@SPNewsAnalysis State of Tennessee Treasury Department Decreases Position in Myriad Genetics, Inc. $MYGN https://t.co/xZAGJS35OV September 21st 2017, 5:09am |
|
@storminvestor State of Tennessee Treasury Department Decreases Position in Myriad Genetics, Inc. $MYGN https://t.co/BvrihdAttu September 21st 2017, 5:09am |
|
@IRAMarketReport Myriad Genetics, Inc. $MYGN Holdings Reduced by Principal Financial Group Inc. https://t.co/3pF1AJxWDR September 21st 2017, 5:09am |
|
@chaffeybreeze Myriad Genetics, Inc. $MYGN Holdings Reduced by Principal Financial Group Inc. https://t.co/SGKthz8MN9 September 21st 2017, 5:09am |
|
@storminvestor Myriad Genetics’ $MYGN “Hold” Rating Reiterated at Cowen and Company https://t.co/62EexoRRYz September 21st 2017, 2:09am |
|
@DavidTraderX $MYGN great looking stock chart, up up and away September 20th 2017, 9:09am |
|
@IRAMarketReport Myriad Genetics, Inc. $MYGN Short Interest Down 12.9% in August https://t.co/0uzqdaH9cH September 20th 2017, 1:09am |
|
@chaffeybreeze Myriad Genetics, Inc. $MYGN Short Interest Down 12.9% in August https://t.co/KJdgbVwT7y September 20th 2017, 1:09am |
 |
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/sNHhSRmye8 September 19th 2017, 5:09pm |
 |
@InsiderAlertsIA $MYGN: New Insider Filing on President & C.E.O. MARK CHRISTOPHER CAPONE: https://t.co/rbX2mS67rr September 19th 2017, 5:09pm |
 |
@emq_news Head to Head Contrast: Myriad Genetics $MYGN versus Varex Imaging $VREX https://t.co/SOilr3N2M7 September 19th 2017, 2:09pm |
 |
@TickerReport Head to Head Contrast: Myriad Genetics $MYGN versus Varex Imaging $VREX https://t.co/dFHZL9t3Lc September 19th 2017, 2:09pm |
|
@TickerReport Head to Head Contrast: Myriad Genetics $MYGN versus Varex Imaging $VREX https://t.co/yrM5wMYmeh September 19th 2017, 2:09pm |
|
@SleekMoneycom Analyzing Myriad Genetics $MYGN & Vascular Solutions $VASC https://t.co/JEWMuEVaaP September 19th 2017, 8:09am |
 |
@TranscriptDaily Myriad Genetics, Inc. $MYGN Stock Rating Reaffirmed by Cowen and Company https://t.co/R6Wq8m07mw September 19th 2017, 3:09am |
|
@dakotafinancial Brokerages Expect Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $182.22 Million https://t.co/oX1SRugyCm September 19th 2017, 1:09am |
|
@CFinancialNews Brokerages Expect Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $182.22 Million https://t.co/Lz3uDSQoiU September 19th 2017, 1:09am |
|
@intercooleronli Brokerages Expect Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $182.22 Million https://t.co/QSSczIrsEr September 19th 2017, 1:09am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.